Common ancestors: chronic progressive diseases have the same pathogenesis.

Area of Science:

• Pathology
• Immunology
• Cell Biology

Background:

• Chronic progressive diseases across organ systems exhibit shared tissue-level changes: increased inflammatory cytokines, cell apoptosis, and fibrosis.
• Elevated systemic inflammatory markers, such as C-reactive protein (CRP), predict disease onset, progression, and complications.
• Therapies reducing inflammatory cytokine expression, like statins, can slow disease progression independently of cholesterol reduction.

Discussion:

• A unifying hypothesis suggests that persistent, unresolved inflammatory responses to noxious stimuli drive chronic disease.
• The fundamental cellular origin from the blastocyst explains the universality of the tissue response, while differentiation accounts for diverse clinical manifestations.
• Understanding this common pathway provides a framework for developing therapies targeting multiple chronic conditions.

Key Insights:

• Persistent inflammation, not just the initial stimulus, is a key driver of chronic progressive diseases.
• Cell apoptosis and fibrosis are common downstream effects of unresolved inflammation across different tissues.
• The shared pathogenesis implies potential for broadly applicable therapeutic interventions.

Outlook:

• Developing therapies that target the common inflammatory pathway could offer a unified approach to treating diverse chronic diseases.
• Further research into the molecular mechanisms linking inflammation, apoptosis, and fibrosis is warranted.
• This framework facilitates testing existing and novel therapeutic strategies at multiple disease intervention points.